Image

Global Hyperhidrosis Treatment Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Hyperhidrosis Treatment Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Hyperhidrosis Treatment Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 607.52 USD Million
Diagram Market Size (Forecast Year) USD 939.45 USD Million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Hyperhidrosis Treatment Market, By Type (Axillary Hyperhidrosis, Palmar Hyperhidrosis, plantar Hyperhidrosis), Treatment (Oral Medications, Over the Counter Antiperspirants, Surgery, Lasers, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Hyperhidrosis Treatment Market

Hyperhidrosis Treatment Market Analysis and Size

The hyperhidrosis treatment market is expected to witness significant growth during the forecast period. Hyperhidrosis is when the patient experiences extreme sweating issues independent of environmental conditions and thermoregulatory requirements. Over-the-counter antiperspirants are often the first line of defense for excessive sweating. Botulinum toxin type A is a safe and effective treatment for focal hyperhidrosis, which lasts longer than topical treatments and does not require invasive surgical procedures.

Data Bridge Market Research analyses a growth rate in the global hyperhidrosis treatment market in the forecast period 2023-2030. The expected CAGR of global Hyperhidrosis treatment market is tend to be around 5.60% in the mentioned forecast period. The market was valued at USD 607.52 million in 2022, and it would grow upto USD 939.45 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Hyperhidrosis Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Axillary Hyperhidrosis, Palmar Hyperhidrosis, plantar Hyperhidrosis), Treatment (Oral Medications, Over the Counter Antiperspirants, Surgery, Lasers, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

GSK Plc (U.K.), TheraVida (U.S.), Revance (U.S.)., NovaMedica. (Russia), Ulthera, Inc. (U.S.), DEMIRA e.V (Germany), Abbvie, Inc (U.S.), Fresh Tracks Therapeutics, Inc. (U.S.), Dr. August Wolff GmbH (Germany), Dermavant Sciences, Inc. (U.S.), Eirion Therapeutics, Inc (U.K.), Kaken Pharmaceutical Co., Ltd. (Japan), Intas Pharmaceuticals Ltd. (India), Roivant Sciences Ltd (Switzerland)

Market Opportunities

  • Increase in Hyperhidrosis Cases
  • Increasing Demand of Botox

Market Definition

Hyperhidrosis disorders are typically characterized by excessive sweating. The excess of sweat in this condition is not even certainly associated with heat or exercise; it is related or concerned to medical abnormality. The extreme sweat occurs in areas of the body such as underarms, palms, face; some people feel the sweat in their shoes and are also unrelated to body temperature. The major cause of the diseases could be the neurologic, endocrine, infectious and other systemic diseases, but healthy people are also likely to report the sufferings from Hyperhidrosis disorders.

Global Hyperhidrosis Treatment Market Dynamics

Drivers

  • Increasing Strategic Partnerships

The strategic partnerships and collaborations between several market players and associations are helping in the growth of the market. For instance, in April 2021, Fortress Biotech, partner company Journey Medicals, entered into a definitive agreement to acquire Qbrexza  in the USA from Dermira, a wholly-owned subsidiary of Eli Lilly. Therefore, the market is projected to witness growth. Though, the short-term results of cosmetic and therapeutic procedures are a major factor limiting the growth of the market.

  • Growing R&D Activities

The latest R&D activities associated with the market are gaining attraction globally. For instance, in October 2021, Brickell Biotech Inc. reported positive topline results from the Phase 3 pivotal Cardigan I and Cardigan II studies that evaluated sofpironium bromide gel, 15% as a once-daily topical formulation in patients having primary axillary hyperhidrosis. This boosts the market growth.

Opportunities

  • Increase in Hyperhidrosis Cases

As per the study published in National Library of Medicine by Jared Brackenrich in October 2021, In the U.S, the incidence of this disorder is projected to be around 3%. Emotional, psychological, social, and occupational impairment can all be caused by hyperhidrosis. Thus, growing burden of hyperhidrosis expected to boost the demand for its treatment thus increase the market growth.

  • Increasing Demand of Botox

According to the article published in International Hyperhidrosis Society of October 2020, Excessive sweating of the armpits, hands, feet, head, and face and other relatively small body areas can be treated with onabotulinumtoxin A. Botox has been shown to reduce sweating by 82-87%. The effects begin to show up 2 to 4 days post treatment, with the full effects generally appearing within two weeks. Dryness lasts 4 to 12 months on average, but few studies have found that it can last up to 14 months.

Restraints/Challenges

  • Side Effects of Botox

Several side effects are associated with botox. Effects such as muscle weakness, vision problems, breathing problems that are deeply affecting the patients and thus hampering the market growth.

  • High Cost

The huge expenditure of the treatment methods impede the market growth. Many times, due to lack of inappropriate payment plans and special considerations by the organizations, the patients fail to adapt these high-end treatment options which in return cost heavy impact on their health. Thus, this is an important restrain that needs to be taken care of.

This global hyperhidrosis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global Hyperhidrosis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Hyperhidrosis Treatment Market

COVID-19 had a neutral impact on the market growth. According to the January 2021 published article titled, Paroxysmal hypothermia and hyperhidrosis with exacerbation after COVID‑19 infection, periods of hypothermia alternated with fever for four days. Although, after the recovery phase, episodic hyperhidrosis and hypothermia continued without fever despite the use of clonidine. Therefore, the demand for hyperhidrosis treatment has increased. According to the International Hyperhidrosis Society in May 2021, sweat could actually help prevent the transmission of COVID-19. Even in the post-pandemic era, the disease and its associated treatment continue rapidly.

Recent Development:

  • In May 2022, Meruho launched Rapifort Wipes in Japan, used for the treatment of primary axillary hyperhidrosis. It is the first prescription wipe preparation in the country.
  • In August 2021, Brickell Biotech, Inc. stated that the final patient had completed the Phase 3 pivotal Cardigan II study, which evaluates sofpironium bromide gel, 15% in patients with primary axillary  hyperhidrosis

Global Hyperhidrosis Treatment Market Scope

The global hyperhidrosis treatment market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Axillary Hyperhidrosis
  • Palmar Hyperhidrosis
  • Plantar Hyperhidrosis

Treatment

  • Oral Medications
  • Anticholinergics
  • Others
  • Over the Counter Antiperspirants
  • Surgery
  • Lasers
  • Others

Route of Administration

End-Users

  • Hospitals
  • Homecare
  • Speciality Centres
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Hyperhidrosis Treatment Market Regional Analysis/Insights

The global hyperhidrosis treatment market is analysed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global Hyperhidrosis treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to favorable healthcare infrastructure, high per capita income, and high rate of adoption of advanced surgeries in the region.

Asia-Pacific dominates the market due to the promotion of research & development activities and awareness.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Hyperhidrosis Treatment Market Share Analysis

The global hyperhidrosis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global hyperhidrosis treatment market.

Key players operating in the global hyperhidrosis treatment market include:

  • GSK Plc (U.K.)
  • TheraVida (U.S.)
  • Revance (U.S.)
  • NovaMedica. (Russia)
  • Ulthera, Inc. (U.S.)
  • DEMIRA e.V (Germany)
  • Abbvie, Inc (U.S.)
  • Fresh Tracks Therapeutics, Inc. (U.S.).
  • Dr. August Wolff GmbH (Germany)
  • Dermavant Sciences, Inc. (U.S.)
  • Eirion Therapeutics, Inc (U.K.)
  • Kaken Pharmaceutical Co., Ltd. (Japan)
  • Intas Pharmaceuticals Ltd. (India)
  • Roivant Sciences Ltd (Switzerland)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Hyperhidrosis Treatment Market is projected to grow at a CAGR of 5.60% during the forecast period by 2030.
The future market value of the Hyperhidrosis Treatment Market is expected to reach USD 939.45 million by 2030.
The major players in the Hyperhidrosis Treatment Market are GSK Plc (U.K.), TheraVida (U.S.), Revance (U.S.)., NovaMedica. (Russia), Ulthera, Inc. (U.S.), DEMIRA e.V (Germany), Abbvie, Inc (U.S.), Fresh Tracks Therapeutics, Inc. (U.S.), Dr. August Wolff GmbH (Germany), etc.
The countries covered in the Hyperhidrosis Treatment Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials